{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:02Z","timestamp":1787071022912,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Negative symptoms of schizophrenia are challenging to treat, contributing to long-term disability and poor prognosis. While conventional TMS has shown proven effective, the evidence supporting intermittent Theta Burst Stimulation (iTBS) is still in the early stages of development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This review aims to accumulate existing evidence on the safety and effectiveness of iTBS for treating negative symptoms in schizophrenia. A better understanding of its effects and outcomes could lead to more targeted treatments, addressing a gap in current therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Search was conducted in three electronic databases: PubMed, ScienceDirect, and Google Scholar, using \u201cITBS\u201d, \u201cSchizophrenia\u201d and \u201cNegative symptoms\u201d as keywords, focusing on RCTs published in the past 10 years related to iTBS and negative symptoms of schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 69 identified articles, 9 were included, involving 440 participants between the ages of 18 to 50 years. Total number of sessions ranged from 10-40 sessions. Stimulation sites varied, including bilateral dorsomedial prefrontal cortex (DMPFC), cerebellum (area VII B and midline), and left and right DLPFC. Most studies used stimulation at 100% or 80% motor threshold. All trials applied consistent iTBS parameters at 50 Hz inner train.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The present review highlights iTBS as a promising non-invasive treatment for negative symptoms in schizophrenia, offering a novel approach for difficult to treat patients in the short duration of the sessions. Evidence supports its potential as part of an integrated treatment strategy, though further research is needed to confirm long-term safety and effectiveness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/indianjpsychiatry_494_25","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:00:10Z","timestamp":1781928010000},"page":"503-509","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of intermittent theta burst stimulation (iTBS) in schizophrenia with predominant negative symptoms: A brief review"],"prefix":"10.4103","volume":"68","author":[{"given":"Nand","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Psychiatry, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Hans","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Madiha","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Narnoli","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"R1-20260626","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(98)07549-7","article-title":"Schizophrenia","volume":"353","author":"Schultz","year":"1999","journal-title":"Lancet"},{"key":"R2-20260626","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mcna.2022.05.005","article-title":"Schizophrenia: One name, many different manifestations","volume":"107","author":"Faden","year":"2023","journal-title":"Med Clin North Am"},{"key":"R3-20260626","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S2215-0366(18)30050-6","article-title":"Negative symptoms of schizophrenia: New developments and unanswered research questions","volume":"5","author":"Galderisi","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"R4-20260626","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41380-023-02043-w","article-title":"The synaptic hypothesis of schizophrenia version III: A master mechanism","volume":"28","author":"Howes","year":"2023","journal-title":"Mol Psychiatry"},{"key":"R5-20260626","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1192\/bjp.bp.114.154526","article-title":"Negative symptoms and longitudinal grey matter tissue loss in adolescents at risk of psychosis: Preliminary findings from a 6-year follow-up study","volume":"208","author":"McKechanie","year":"2016","journal-title":"Brit J Psychiatry"},{"key":"R6-20260626","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2215-0366(19)30475-4","article-title":"The burden of mental disorders across the states of India: The Global Burden of Disease Study 1990\u20132017","volume":"7","author":"Sagar","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"R7-20260626","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pneurobio.2016.07.004","article-title":"New drug developments in psychosis: Challenges, opportunities and strategies","volume":"152","author":"Keshavan","year":"2017","journal-title":"Prog Neurobiol"},{"key":"R8-20260626","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S1092852914000601","article-title":"Thinking and acting beyond the positive: The role of the cognitive and negative symptoms in schizophrenia","volume":"19","author":"Carbon","year":"2014","journal-title":"CNS Spectr"},{"issue":"(Suppl 2)","key":"R9-20260626","first-page":"8569","article-title":"Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia","volume":"77","author":"Green","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"R10-20260626","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2016.05.015","article-title":"Treatment of negative symptoms: Where do we stand, and where do we go?","volume":"186","author":"Aleman","year":"2017","journal-title":"Schizophr Res"},{"key":"R11-20260626","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.psychres.2015.07.022","article-title":"Cascading and combined effects of cognitive deficits and residual symptoms on functional outcome in schizophrenia\u2013a path-analytical approach","volume":"229","author":"Bhagyavathi","year":"2015","journal-title":"Psychiatry Res"},{"key":"R12-20260626","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2015.03.033","article-title":"Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity","volume":"165","author":"Strassnig","year":"2015","journal-title":"Schizophr Res"},{"key":"R13-20260626","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/11586650-000000000-00000","article-title":"Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia","volume":"25","author":"Singh","year":"2011","journal-title":"CNS Drugs"},{"key":"R14-20260626","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of negative symptoms in schizophrenia: Meta-analysis of 168 randomized placebo-controlled trials","volume":"41","author":"Fusar-Poli","year":"2015","journal-title":"Schizophr Bull"},{"key":"R15-20260626","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2015.06.008","article-title":"Clinical management of negative symptoms of schizophrenia: An update","volume":"153","author":"Tsapakis","year":"2015","journal-title":"Pharmacol Thera"},{"key":"R16-20260626","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/appi.ajp.2016.15081035","article-title":"Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: A systematic review and meta-analysis","volume":"173","author":"Helfer","year":"2016","journal-title":"Am J Psychiatry"},{"key":"R17-20260626","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41537-021-00138-3","article-title":"Intermittent theta burst stimulation for negative symptoms of schizophrenia\u2014A double-blind, sham-controlled pilot study","volume":"7","author":"Bation","year":"2021","journal-title":"NPJ Schizophr"},{"key":"R18-20260626","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.brs.2020.02.016","article-title":"A randomized, double blind, sham-controlled trial of repetitive transcranial magnetic stimulation (rTMS) in the treatment of negative symptoms in schizophrenia","volume":"13","author":"Kumar","year":"2020","journal-title":"Brain Stimul"},{"key":"R19-20260626","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2007.06.019","article-title":"Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study","volume":"95","author":"Prikryl","year":"2007","journal-title":"Schizophr Res"},{"key":"R20-20260626","doi-asserted-by":"crossref","first-page":"e01611","DOI":"10.1002\/brb3.1611","article-title":"Antipsychotic agents deteriorate brain and retinal function in schizophrenia patients with combined auditory and visual hallucinations: A pilot study and secondary follow-up study","volume":"10","author":"Zhuo","year":"2020","journal-title":"Brain Behav"},{"key":"R21-20260626","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/da.20454","article-title":"A randomized trial of the anti-depressant effects of low-and high-frequency transcranial magnetic stimulation in treatment-resistant depression","volume":"26","author":"Fitzgerald","year":"2009","journal-title":"Depress Anxiety"},{"key":"R22-20260626","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.4088\/JCP.v68n1009","article-title":"Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine","volume":"68","author":"Rosa","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R23-20260626","doi-asserted-by":"crossref","first-page":"101966","DOI":"10.1016\/j.nicl.2019.101966","article-title":"Dynamic functional connectivity in schizophrenia and autism spectrum disorder: Convergence, divergence and classification","volume":"24","author":"Rabany","year":"2019","journal-title":"Neuroimage Clin"},{"key":"R24-20260626","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2004.12.033","article-title":"Theta burst stimulation of the human motor cortex","volume":"45","author":"Huang","year":"2005","journal-title":"Neuron"},{"key":"R25-20260626","doi-asserted-by":"crossref","first-page":"115033","DOI":"10.1016\/j.psychres.2022.115033","article-title":"Effectiveness of accelerated intermittent theta burst stimulation for social cognition and negative symptoms among individuals with schizophrenia: A randomized controlled trial","volume":"320","author":"Jin","year":"2023","journal-title":"Psychiatry Res"},{"key":"R26-20260626","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.brs.2025.03.014","article-title":"Accelerated iTBS with a personalised targeting method to treat negative symptoms of schizophrenia: A randomized controlled trial","volume":"18","author":"Han","year":"2025","journal-title":"Brain Stimul"},{"key":"R27-20260626","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/appi.ajp.2018.18040429","article-title":"Cerebellar-prefrontal network connectivity and negative symptoms in schizophrenia","volume":"176","author":"Brady","year":"2019","journal-title":"Am J Psychiatry"},{"key":"R28-20260626","first-page":"569","article-title":"Cerebellar vermal atrophy in psychiatric patients","volume":"17","author":"Heath","year":"1982","journal-title":"Biol Psychiatry"},{"key":"R29-20260626","doi-asserted-by":"crossref","first-page":"114204","DOI":"10.1016\/j.psychres.2021.114204","article-title":"Cerebellar theta burst stimulation for the treatment of negative symptoms of schizophrenia: A multicenter, double-blind, randomized controlled trial","volume":"305","author":"Zhu","year":"2021","journal-title":"Psychiatry Res"},{"key":"R30-20260626","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2021.10.005","article-title":"Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative symptoms: A randomized controlled trial","volume":"238","author":"Basavaraju","year":"2021","journal-title":"Schizophr Res"},{"key":"R31-20260626","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/NDT.S468219","article-title":"Efficacy of Cortical-hippocampal target intermittent theta burst stimulation (iTBS) on associative memory of schizophrenia: A double-blind, randomized sham-controlled trial","volume":"20","author":"Li","year":"2024","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R32-20260626","doi-asserted-by":"crossref","first-page":"103715","DOI":"10.1016\/j.nicl.2024.103715","article-title":"Effects of parietal iTBS on resting-state effective connectivity within the frontoparietal network in patients with schizophrenia: An fMRI study","volume":"45","author":"Li","year":"2025","journal-title":"Neuroimage Clin"},{"key":"R33-20260626","doi-asserted-by":"crossref","first-page":"1500113","DOI":"10.3389\/fpsyt.2024.1500113","article-title":"Intermittent theta burst stimulation for negative symptoms in schizophrenia patients with mild cognitive impairment: A randomized controlled trail","volume":"15","author":"Li","year":"2025","journal-title":"Front Psychiatry"},{"key":"R34-20260626","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/pcn.13779","article-title":"Intermittent theta burst stimulation for negative symptoms in schizophrenia patients with moderate to severe cognitive impairment: A randomized controlled trial","volume":"79","author":"Li","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"R35-20260626","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2021.04.053","article-title":"Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression\u2013A randomized controlled trial","volume":"290","author":"Bod\u00e9n","year":"2021","journal-title":"J Affect Disord"},{"key":"R36-20260626","doi-asserted-by":"crossref","first-page":"115743","DOI":"10.1016\/j.psychres.2024.115743","article-title":"Effects of right prefrontal theta-burst transcranial magnetic stimulation or transcranial direct current stimulation on apathy in patients with schizophrenia: A multicenter RCT","volume":"333","author":"Kos","year":"2024","journal-title":"Psychiatry Res"},{"key":"R37-20260626","doi-asserted-by":"crossref","first-page":"1308971","DOI":"10.3389\/fpsyg.2024.1308971","article-title":"Combining transcranial magnetic stimulation with training to improve social cognition impairment in schizophrenia: A pilot randomized controlled trial","volume":"15","author":"Vergallito","year":"2024","journal-title":"Front Psychol"},{"key":"R38-20260626","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpsychires.2024.11.055","article-title":"Motor cortex excitability in schizophrenia or depression and its modulation with prefrontal intermittent theta-burst stimulation","volume":"181","author":"Th\u00f6rnblom","year":"2025","journal-title":"J Psychiatric Res"},{"key":"R39-20260626","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/brainsci14010018","article-title":"Efficacy of using intermittent theta burst stimulation to treat negative symptoms in patients with schizophrenia\u2014A systematic review and meta-analysis","volume":"14","author":"Tan","year":"2023","journal-title":"Brain Sci"},{"key":"R40-20260626","doi-asserted-by":"crossref","first-page":"944437","DOI":"10.3389\/fphar.2022.944437","article-title":"Efficacy and safety of intermittent theta-burst stimulation in patients with schizophrenia: A meta-analysis of randomized sham-controlled trials","volume":"13","author":"Goh","year":"2022","journal-title":"Front Pharmacol"},{"key":"R41-20260626","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clinph.2013.06.187","article-title":"Determination of motor threshold using visual observation overestimates transcranial magnetic stimulation dosage: Safety implications","volume":"125","author":"Westin","year":"2014","journal-title":"Clin Neurophysiol"},{"key":"R42-20260626","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/hbm.23882","article-title":"Impact of different intensities of intermittent theta burst stimulation on the cortical properties during TMS-EEG and working memory performance","volume":"39","author":"Chung","year":"2018","journal-title":"Hum Brain Mapp"},{"key":"R43-20260626","doi-asserted-by":"crossref","first-page":"676","DOI":"10.5152\/alphapsychiatry.2024.241799","article-title":"Adjunctive intermittent theta-burst stimulation for schizophrenia: A systematic review and meta-analysis of randomized double-blind controlled studies","volume":"25","author":"Wen","year":"2024","journal-title":"Alpha Psychiatry"},{"key":"R44-20260626","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3390\/brainsci14111067","article-title":"Is it possible to combine non-invasive brain stimulation and evidence-based psychosocial interventions in schizophrenia? A critical review","volume":"14","author":"Lisoni","year":"2024","journal-title":"Brain Sci"},{"key":"R45-20260626","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41537-022-00248-6","article-title":"The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: A systematic review and meta-analysis","volume":"8","author":"Lorentzen","year":"2022","journal-title":"Schizophr"},{"key":"R46-20260626","doi-asserted-by":"crossref","first-page":"766736","DOI":"10.3389\/fneur.2021.766736","article-title":"Potential locations for non-invasive brain stimulation in treating schizophrenia: A resting-state functional connectivity analysis","volume":"12","author":"Ning","year":"2021","journal-title":"Front Neuro"},{"key":"R47-20260626","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/WNP.0b013e318205135f","article-title":"Safety of theta burst transcranial magnetic stimulation: A systematic review of the literature","volume":"28","author":"Oberman","year":"2011","journal-title":"J Clin Neurophysiol"},{"key":"R48-20260626","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajp.2019.02.003","article-title":"Accelerated transcranial magnetic stimulation for the treatment of patients with depression: A review","volume":"40","author":"Rachid","year":"2019","journal-title":"Asian J Psychiatry"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_494_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:28Z","timestamp":1787067628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_494_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/indianjpsychiatry_494_25","relation":{},"ISSN":["0019-5545","1998-3794"],"issn-type":[{"value":"0019-5545","type":"print"},{"value":"1998-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2025-05-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}